MAGEB2 was analyzed for tumors from neurofibromatosis type 1 patients.
MAGEB2 is methylated in normal Schwann cells and any types of neurofibroma.
MAGEB2 can be aberrantly demethylated in malignant peripheral nerve sheath tumors.
MAGEB2 can be aberrantly expressed in malignant peripheral nerve sheath tumors.